News & Views

Featured
1 min read

Remarque Systems named one of the 10 best CTMS to watch in 2022!

Modern clinical trials generate reams of data from multiple sources, creating enormous information management challenges for sponsors. Today, the growing popularity of decentralized clinical trials (DCTs) only exacerbates the problem. It is not enough to cobble together multiple management systems; these new approaches to trials require new clinical trial management systems (CTMS). A modern CTMS

Subscribe to Our Blog. Stay up to date with the latest news and insights.

1 min read

ACRP | DCTs: Key Considerations for Small-to-Midsized Biotechnology and Biopharmaceutical Companies

Decentralized clinical trials (DCTs) are no fad; they are entrenched in the future of clinical development.

1 min read

Applied Clinical Trials: Unraveling DCT Misconceptions

DCTs can be a great tool for small-to-midsize pharma and biotech companies despite misconceptions of them being advantageous for only Big Pharma.

Exhibition & Speaking Events

scoe-og
03 Oct

SCOPE Europe 2022, Barcelona

October 3-4, 2022 Booth #25

Visit Remarque Systems at SCOPE Europe 2022, booth #25, to discuss the common challenges and trends in clinical trial insights. Learn how we can help improve the quality of your clinical trial data.

On Monday 3rd October at 15:20, Joseph Goodgame, Co-Founder and CTO, Remarque Systems
& Andrea Ochoa, MS, Senior Vice President, Clinical Development EMEA & APAC,
Premier Research will be presenting: The Road to Successful Risk Monitoring in Clinical
Studies
The presentation will demonstrate that a consistent, unified approach to risk
assessment that encompasses multiple monitoring platforms — on-site, remote,
centralized, and risk-based — can create a process and organization structure that
positions you for success in any circumstance.

InterContinental Barcelona Avenida Rius I Taulet 1-3
Barcelona, 08004 Spain

https://www.scopesummiteurope.com/

Webinars

Our webinars feature thought leaders from CROs, agile biotechs, and large pharmaceutical companies to bring you educational and scientific insights on a variety of subjects. Browse our on demand library for the latest insights.

Webinar-1

Unprecedented Data-Monitoring Backlogs & How To Deal With It

Kristin Mauri & Rhonda Roberts

Recently, industry publications have filled with COVID-19-related clinical trial stories. As biotech and pharma companies the world over the race for a vaccine or a cure, there is another pandemic tale that is going unheralded: the virtual halt to real progress on clinical trials for anything except COVID-19. Though most fully halted trials were just…

webinar

Sharp Thinking: A New Angle on Clinical Trial Management Systems

New technologies are inevitably heralded as making life simpler: streamlining tasks, eliminating steps, managing things so you don’t have to manage them. Yet the practical application of a new technology often seems to make things more complex.

Clinical trial management is a case in point. 

shutterstock 2070912257

Key Considerations When Implementing a Decentralized Clinical Trial

Remarque Systems | Curebase

The popularity of decentralized clinical trials (DCTs) is surging—especially among patients. Harnessing the technology of all kinds, these trials provide an attractive alternative to the old-style site-anchored system on which traditional clinical trials have rested. They also have the potential to provide better, more timely data since that data is largely collected under real-life situations and often available more quickly to monitoring teams.

shutterstock 2136489279

CTMS Evolution: Adapting to Advancements in Clinical Trials

Meghan Donahue Product Owner

Clinical trial management systems, the software tools that underpin modern clinical research, have evolved dramatically since CTMS technology debuted about 20 years ago and since 2011, when Pfizer conducted the first entirely web-based trial. Still, the systems the industry largely relies on today are outdated and in need of modernization.

Networking Events

Our team is geared up and ready to meet you all over the world. We’re excited to connect to learn more about your needs at the following conferences. Contact us to schedule a meeting at any of the conferences below.

OCT Southern California

September 28 - 29 2022
October 12 - 13 2022

FAQs

What is the Remarque Systems platform?

The Remarque Systems platform is one single integrated solution that connects clinical trial data by centralizing all data sources without the complexity of using multiple separate components. Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time.

Key highlights of our platform are:

  • Holistic risk management
  • Data analytics including AI and machine learning

Is the Remarque Systems platform an Electronic Data Collection (EDC) system?

No. EDC systems are one of the methods that data is collected on a clinical trial. The Remarque systems platform is designed to manage a clinical trial no matter how the data is collected (EDC, EMR, eSource, Device, Labs, Safety Systems etc.)

Is the Remarque Systems platform a Clinical Trial Management System (CTMS)?

The Remarque Systems platform is more than just a CTMS. While a traditional CTMS is only designed to manage onsite monitoring, the current environment requires a system to support the three different types of monitoring (Onsite, Remote and Centralized).

The Remarque Systems platform allows you to replace your CTMS and meet regulatory needs on other types of monitoring.

What additional functionality does Remarque Systems platform have?

The Remarque Systems platform is designed to be a comprehensive toolset for managing a clinical study.

The platform supports the following functions:

  • Machine learning
  • Template library
  • Data ingest
  • Data analytics
  • Workflows
  • Alerts
  • Action items

 

How is Remarque Systems different from other systems?

  • Ecosystem compatibility with existing systems & processes
  • RBM audit trail
  • System configurability vs customizations
  • Customer experience & development teams
  • Operational & analytical platform in one system
  • Continuous improvement and expansion of platform

Can the Remarque Systems platform be used in all therapeutic areas?

Yes. With our platform, you can receive benefit from our knowledge gained in specific therapeutic areas. The Remarque Systems platform has proven itself across multiple therapeutic areas.

How long does it take to launch a Study?

In general it takes four-to-six weeks to get a study up and running. Much of this time is dependent on the length of time the customer requires for their own UAT activities. If system templates are being applied to create new studies over time, the length of time to launch a study can significantly decrease.

Can we manage the system ourselves?

The platform was designed to be self-service but we provide multiple tiers of support to our client base. Normally we provide support to our clients for the first study and then afterwards train the customer on all of the self-service aspects.

Do I have to buy the entire platform, or can I pick and choose the modules I want?

You are able to pick and choose the modules you want. Our platform is designed to easily fit into your existing ecosystem.

Can the Sponsor/CRO provide Data Management?

Yes, the ability for the platform to support multiple players in managing a clinical trial is essential. It is common that data management is provided by a team or company other than Risk management or Medical monitoring etc.

What type of clients do you have?

We work with all companies in the Pharmaceutical, Biotech, Device, CRO and ARO.

Do you work with CROs?

Yes, CROs have unique challenges not experienced by sponsors in that they must frequently manage to different standards driven by their customers. We have ensured the design of the Remarque Systems platform to fully support that.

How can you access the system?

As a true SAAS platform, access is via the web over secure https connectivity.

Who gets access the system?

System access is controlled by the client. Access is granted directly in the platform and supports both local accounts and fully federated solutions with SSO.

Is there any limit to the number of users of any kind?

There is no limit to number of users. Additionally, costs are not driven by users.

Is your platform validated?

Yes, our platform is validated.

How secure is the system?

As a multi-tennant SAAS platform, security is of paramount concern. We leverage all available security methods with our hosting provider and regularly test the application for security vulnerabilities.

Do you have Business Continuity and Disaster Recovery Plan?

Yes.

Have you been audited?

Yes, we have been audited multiple times by our clients.

How do you support your studies?

A client service representative is assigned to each study and will support and help organizations configure the system to meet their needs. In addition, we have a helpdesk support team who can deal with technical issues or product questions.

How do you perform the training?

Training is offered in a variety of different ways, including training manuals, help text within the application, and e-learning modules, and remote or live training classes.

Do you operate internationally? Where have you conducted studies?

We have conducted studies globally.

How do I start?

Please feel free to Request a demo, call us at (919) 261-5830 or email us at info@RemarqueSystems.com.